Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma

NCT04535271 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Leiomyosarcoma

Interventions

DRUG: Trabectedin

Sponsor

Sarcoma Oncology Research Center, LLC